Centaurus Financial »

Aurinia Pharmaceuticals shares owned by Centaurus Financial

Quarter-by-quarter ownership of Aurinia Pharmaceuticals (AUPH) shares owned by Centaurus Financial from 13F filings

Historical chart of Centaurus Financial investment in Aurinia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Aurinia Pharmaceuticals held by Centaurus Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aurinia Pharmaceuticals by Centaurus Financial

Quarter filed Position value Share count Share price at filing
2026-03-31 $904k 61k 14.81

More positions owned by Centaurus Financial

NVIDIA Corporation (NVDA)
Apple (AAPL)
Tidal Trust Iii Nestyield Vision (EGGQ)
Tidal Trust Iii Nestyield Dynami (EGGY)
Amazon (AMZN)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Tidal Trust Iii Nestyield Total (EGGS)
Broadcom (AVGO)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
Spdr Series Trust State Street Spd (BIL)
Tesla Motors (TSLA)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Centaurus Financial

Top funds holding Aurinia Pharmaceuticals

Tang Capital Management
BlackRock
NEA Management Company
Two Sigma Investments
Arrowstreet Capital, Limited Partnership
State Street Corporation
Morgan Stanley
Renaissance Technologies
Marshall Wace
D. E. Shaw & Co
Geode Capital Management
Vanguard Group
Goldman Sachs Group
Vanguard Portfolio Management
Jacobs Levy Equity Management

View all funds holding Aurinia Pharmaceuticals